AZUL AZUL
Company Profile ↓Company Overview
AZUL (AZUL) is a publicly traded company listed on with a market capitalization of $7.75B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Revenue has grown at a 10.7% CAGR over the past five years.
Recent Developments
- Dec 2025 Revenue of $21.64B (+10.8% YoY); net profit $124.86M.
- Trailing 12 Months Year-on-year growth — revenue +10.8%.
- 5-Year Trend Long-term compounding — revenue CAGR 10.7%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 10.71% |
| 1 Year: | 10.83% |
Stock Price Performance
| 1 Year: | -4.21% |
| 6 Months: | - |
| 3 Months: | - |
| 1 Month: | -3.89% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- RSI (14)47.71 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 10.7% over 5 years.
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Revenue | - | 5.39B | 4.94B | 5.74B | 5.57B | 5.47B |
| Cost of Revenue | - | 3.13B | 3.75B | 4.12B | 2.89B | 4.16B |
| Gross Profit | - | 2.26B | 1.20B | 1.62B | 2.68B | 1.31B |
| Operating Expenses | - | 783.01M | 816.00M | 941.92M | 1.63B | 635.09M |
| Operating Income | - | 1.48B | 379.90M | 673.62M | 1.05B | 675.96M |
| EBITDA | - | 3.99B | 3.67B | 1.56B | 620.37M | 500.60M |
| Interest Expense | - | 1.53B | 1.62B | 2.21B | 1.53B | 1.34B |
| Pretax Income | - | 1.65B | 1.29B | -1.37B | -1.63B | -1.49B |
| Tax Provision | - | 15.00K | 0 | 0 | -15.00K | -7.51B |
| Net Income | - | 1.65B | 1.29B | -1.37B | -1.63B | 6.02B |
| Diluted EPS | - | 7.66 | 56,625,000.14 | -750,000.00 | -3.70 | 11,430,000.00 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 15.95B | 18.55B | 19.53B | 21.64B |
| Cost of Revenue | - | 12.78B | 13.47B | 13.61B | 14.46B |
| Gross Profit | - | 3.17B | 5.09B | 5.92B | 7.18B |
| Operating Expenses | - | 2.84B | 3.67B | 2.67B | 4.01B |
| Operating Income | - | 326.76M | 1.42B | 3.25B | 3.17B |
| EBITDA | - | 5.61B | 4.62B | -1.77B | 9.96B |
| Interest Expense | - | 4.24B | 4.56B | 4.86B | 6.83B |
| Pretax Income | - | -722.37M | -2.34B | -9.19B | 124.87M |
| Tax Provision | - | 0 | 39.53M | -38.80M | 12.00K |
| Net Income | - | -722.37M | -2.38B | -9.15B | 124.86M |
| Diluted EPS | - | -8.23 | -4.18 | -13,125,000.03 | -0.50 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 18.72B | 20.53B | 26.27B | 23.64B |
| Current Assets | - | 4.87B | 5.04B | 5.66B | 6.30B |
| Cash & Equivalents | - | 668.35M | 1.90B | 1.21B | 991.64M |
| Inventory | - | 721.74M | 799.21M | 943.58M | 972.53M |
| Receivables | - | 1.80B | 1.11B | 1.78B | 2.72B |
| Total Liabilities | - | 37.73B | 41.86B | 56.71B | 52.68B |
| Current Liabilities | - | 15.06B | 14.75B | 21.34B | 29.47B |
| Long Term Debt | - | 7.51B | 9.77B | 13.83B | 9.58B |
| Total Debt | - | 23.97B | 26.34B | 37.54B | 36.17B |
| Total Equity | - | -19.01B | -21.33B | -30.44B | -29.04B |
| Shares Outstanding | - | 335.62M | 335.75M | 335.75M | 896.04M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 2.44B | 3.44B | 2.79B | -1.23B |
| Investing Cash Flow | - | -639.85M | -874.48M | -1.57B | -573.38M |
| Financing Cash Flow | - | -4.20B | -1.39B | -1.92B | 1.71B |
| Capital Expenditure | - | -1.45B | -972.32M | -1.49B | -747.91M |
| Free Cash Flow | - | 986.26M | 2.47B | 1.29B | -1.98B |
| Net Change in Cash | - | -2.41B | 1.17B | -698.74M | -96.97M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 19.9% | 27.4% | 30.3% | 33.2% |
| Operating Margin % | - | 2.0% | 7.6% | 16.6% | 14.6% |
| Net Margin % | - | -4.5% | -12.8% | -46.9% | 0.6% |
| ROE % | - | 3.8% | 11.2% | 30.1% | -0.4% |
| ROCE % | - | 8.9% | 24.5% | 65.8% | -54.3% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for AZUL
Azul stock nosedives amid major dilution - Valor International
<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxQem9jS2Z2MkR5dThidDVZS0FiNDZGNlBlNTN1ejI2R0VZZVVoeGpETGtSX2FQa3hQZ1k0SDRIbGh1dUl4LUt2aV80UC1IdFN6NldMVUp2RXZLWkJRSUZROEU4MTk2OUptRm1xMVNTNGJ5SXVJak11N0loRW5ZSmtJU3Z0TDBseVhwcEdrbl…
Brazil's Azul launches share offering to raise $1.33 billion - Reuters
<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxOR3VMbTBid2ZYU3B4MVdYYm5uUGUydXVhUUw1OTdqel80SU5rVXBNOFcxLVpCbjNQMGQ3ZkhiZjJTX1p2d19UUFdOWTNJc3A0YXo2X0pIRHJuenJzZHVneUUxRWxMdVo3T0lKNUN6RHRsakN3WGtaeFlpU3pUTXJTUnNXcnN4dVFrR2ZaWX…
Azul S.A. (NYSE: AZUL) delists from NYSE American and lists on NYSE - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxNTl85bDFiYVBxTEpUdUlHVGIyMGZ4RmZidXc1YVlNWkpySUVPSmJjQWxDQTgtLTljOGR2WWs4dEhXSlV0empVY0pDbzNSQUdGTEx0LU1adnkzcDFZUDNiaEZMNXdBbmNBS0lsMjdmcUNlNmp4cU9ETk5rUDhqeHlkUWU2M1FocXZRZ2x3?o…
Azul CEO John Rodgerson delivers remarks as its stock uplists to NYSE - qz.com
<a href="https://news.google.com/rss/articles/CBMic0FVX3lxTE53djJRcmV4U0NNWDQ1T05kVmdvSmZINzFld00zRU85dkNaMXBucWRJalRVZUtBY3lELUc0a3gyVnQ4WU9ES3NXc2Nnb0FBZUhfZE1TWEJnQkJhLS1CV3BEMmkwODRqRkE5VXJDWnFoUnN5Smc?oc=5" target="_blank">Azul CEO Joh…
Brazil’s Azul approves reverse stock split - ch-aviation
<a href="https://news.google.com/rss/articles/CBMiiAFBVV95cUxOOTNPZTVQeGNfRFhpYy10U3BwUEJ6VHFpaml0QVRuSEZLZ0d0dVNheE5FQTVxUF9scjZvd0hwc2hvcmdKVjhiUWIwRC12RWNtam9vVC1LMERqWkVYb0JKU0FlZDJPS1h4RGhMN0lOUzdaR1k2MXdiVDJjSUs0UlNPRnE5LWh1T2dS?oc=5"…
Azul Emerges From Bankruptcy As A High-Risk Buy (NYSE:AZUL) - Seeking Alpha
<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxNZW9veGhjMi1ZTFhfM0xkdVhPd2lCei1QbEJ4amNuNEl6R2pYcXdXbVI0RzVfNnhiZFFPRzcwajZWSDFNU1Jvd1NwOGk5X2VOb09OSVlhdXE2Ym9zNmh2U1ZDVEQ2X1FNd1ZwcTFjQ01BOXozYjlJVFNTMUVYSGZkRDFnRDhwMUcwZWUzLW…
AZUL — Frequently Asked Questions
What is the current share price of AZUL?
As of 2026-08-05 17:25 PDT, AZUL trades at $8.65 on NASDAQ/NYSE. Its 52-week range is $8.30 to $9.83.
What is the market capitalisation of AZUL?
AZUL has a market capitalisation of $7.75B on NASDAQ/NYSE.
What is the P/E ratio of AZUL?
AZUL trades at a trailing price-to-earnings (P/E) ratio of -17.25. Its price-to-book (P/B) ratio is -0.27.
What is the return on equity (ROE) of AZUL?
AZUL has a return on equity (ROE) of -0.43%. Its return on capital employed (ROCE) is -54.29%.
Is AZUL a good stock to buy?
This page provides a data-driven analysis of AZUL, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.